People · Operator
Named in public records as an officer, director or promoter · active 2022–2026 · Biotechnology, Biotech / Pharma
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Ramona Optics, Inc. | — | Biotechnology | Series B | $27.9M | $91.4M | 2026 |
| Protillion Biosciences, lnc. | — | Biotech / Pharma | Series B | $19.0M | $256.6M | 2022 |
Sean Kendall at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Sean Kendall on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| David Walt | 1 | 6 |
| Malek Faham | 1 | 3 |
| Robert Horstmeyer | 1 | 2 |
| Margaret Aery | 1 | 1 |
| Patrick Weiss | 1 | 1 |
| Gregor Horstmeyer | 1 | 1 |
| Mark Harfouche | 1 | 1 |
| Curtis Layton | 1 | 1 |
| Michael Shepherd | 1 | 1 |
| Roarke Horstmeyer | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.